Sympathetic control of bone mass regulated by osteopontin

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 43, 2011, Pages 17767-17772

  Nagao, Masashi ^a,b   Feinstein, Timothy N ^f   Ezura, Yoichi ^a   Hayata, Tadayoshi ^a   Notomi, Takuya ^a   Saita, Yoshitomo ^b   Hanyu, Ryo ^a,b   Hemmi, Hiroaki ^a   Izu, Yayoi ^a   Takeda, Shu ^a   Wang, Kathryn ^c   Rittling, Susan ^d   Nakamoto, Tetsuya ^a   Kaneko, Kazuo ^b   Kurosawa, Hisashi ^b   Karsenty, Gerard ^e   Denhardt, David T ^c   Vilardaga, Jean Pierre ^f   Noda, Masaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c RUTGERS UNIVERSITY   (United States)

^d FORSYTH INSTITUTE   (United States)

^e Columbia University ^*  (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

G protein coupled receptor; Osteoblast; Osteoporosis

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ISOPRENALINE; MESSENGER RNA; OSTEOPONTIN;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; BONE LEVEL; BONE MASS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FLUORESCENCE RESONANCE ENERGY TRANSFER; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SYMPATHETIC TONE; TRABECULAR BONE; TRANSCRIPTION REGULATION;

ANALYSIS OF VARIANCE; ANIMALS; BONE AND BONES; CYCLIC AMP; FLUORESCENCE RESONANCE ENERGY TRANSFER; ISOPROTERENOL; MICE; OSTEOBLASTS; OSTEOCLASTS; OSTEOPONTIN; RECEPTORS, ADRENERGIC, BETA-2; SYMPATHETIC NERVOUS SYSTEM;

MURINAE; MUS;

EID: 80055083021     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1109402108     Document Type: Article

References (22)

1. Kanis JA, et al. (2003) The components of excess mortality after hip fracture. Bone 32:468-473. (Pubitemid 39665705)
2. Lanyon L, Skerry T (2001) Postmenopausal osteoporosis as a failure of bone's adaptation to functional loading: a hypothesis. J Bone Miner Res 16:1937-1947. (Pubitemid 32995384)
3. Ehrlich PJ, Lanyon LE (2002) Mechanical strain and bone cell function: a review. Osteoporos Int 13:688-700. (Pubitemid 35000996)
4. Noda M, ed (2011) Mechanosensing Biology (Springer, Tokyo).
5. Raisz LG (2005) Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115:3318-3325.
6. Karsenty G (2006) Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab 4:341-348.
7. Elefteriou F (2008) Regulation of bone remodeling by the central and peripheral nervous system. Arch Biochem Biophys 473:231-236.
8. Kondo H, et al. (2005) Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system. J Biol Chem 280:30192-30200. (Pubitemid 41216198)
9. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS (2001) Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 107:1055-1061. (Pubitemid 32422899)
10. Ishijima M, et al. (2001) Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin. J Exp Med 193:399-404. (Pubitemid 32524523)
11. Ishijima M, et al. (2002) Resistance to unloading-induced three-dimensional bone loss in osteopontin-deficient mice. J Bone Miner Res 17:661-667. (Pubitemid 34246641)
12. Rittling SR, et al. (1998) Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 13:1101-1111. (Pubitemid 28311778)
13. Shinohara ML, Kim JH, Garcia VA, Cantor H (2008) Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. Immunity 29:68-78.
14. Cantor H, Shinohara ML (2009) Regulation of T-helper-cell lineage development by osteopontin: the inside story. Nat Rev Immunol 9:137-141.
15. Nikolaev VO, Bünemann M, Hein L, Hannawacker A, Lohse MJ (2004) Novel single chain cAMP sensors for receptor-induced signal propagation. J Biol Chem 279:37215-37218. (Pubitemid 39195424)
16. Violin JD, et al. (2008) β2-adrenergic receptor signaling and desensitization elucidated by quantitative modeling of real time cAMP dynamics. J Biol Chem 283:2949-2961.
17. Feinstein TN, et al. (2011) Retromer terminates the generation of cAMP by internalized PTH receptors. Nat Chem Biol 7:278-284.
18. Wang KX, Denhardt DT (2008) Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev 19:333-345.
19. Diao H, et al. (2004) Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity 21:539-550. (Pubitemid 39370509)
20. Shinohara ML, Kim HJ, Kim JH, Garcia VA, Cantor H (2008) Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells. Proc Natl Acad Sci USA 105:7235-7239. (Pubitemid 351754461)
21. Chruscinski AJ, et al. (1999) Targeted disruption of the β2 adrenergic receptor gene. J Biol Chem 274:16694-16700.
22. Ferrandon S, et al. (2009) Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Nat Chem Biol 5:734-742.